CHECKMATE PHARMACEUTICALS IN (CMPI) Stock Analyst Earnings Estimates
NASDAQ:CMPI - Nasdaq - US1628181083 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 2.94% | N/A 5.00% | |||||
| EBITDA YoY % growth | N/A | N/A | N/A | -61.4M | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20.99M | -28.89M -37.64% | -37M -28.07% | -61.47M -66.14% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.84 14.85% | N/A -8.64% | N/A 24.63% | N/A -87.28% | N/A 32.67% | N/A 31.33% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.77 13.07% | -0.76 -10.13% | -0.79 -26.68% | -0.78 -6.19% | -0.78 -1.33% | -0.77 -0.67% | -0.77 2.60% |
| Revenue Q2Q % growth | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -0.73 -12.31% | -0.77 | 0.04 | 4.58% |
| Q4 2021 Q2Q % growth | -0.62 1.59% | -0.76 | 0.14 | 18.23% |
| Q3 2021 Q2Q % growth | -0.69 17.86% | -0.73 | 0.04 | 5.17% |
| Q2 2021 Q2Q % growth | -0.88 88.06% | -0.76 | -0.12 | -16.06% |
| Q1 2021 Q2Q % growth | -0.65 | -0.72 | 0.07 | 9.61% |
| Q4 2020 Q2Q % growth | -0.63 | -0.48 | -0.15 | -31.41% |
| Q3 2020 Q2Q % growth | -0.84 | -0.47 | -0.37 | -78.06% |
| Q2 2020 Q2Q % growth | -7.37 | -0.60 | -6.77 | -1,135.13% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |